Skip Page Header

Home > EMCDDA–Europol joint report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate (carfentanil).

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol joint report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate (carfentanil). Luxembourg: Publications Office of the European Union. 19 p.

[img]
Preview
PDF (Carfentanil) - Published Version
336kB

In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 27 July 2017.

Table of contents

  • Introduction
  • Information collection process
  • Information required by Article 5.2 of the Council Decision
  • Information from the EMA (Article 5.3 of the Council Decision)
  • Conclusion
  • References
Item Type
Evidence resource
Publication Type
Report
Drug Type
New psychoactive substance
Date
November 2017
Pages
19 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page